ArticleScience China. Life sciences2026
Sgf29 regulates pluripotency by maintaining chromatin accessibility and promoting the expression of core transcription factors.
Article in Science China. Life sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The pluripotency state of embryonic stem cells (ESCs) is determined by both their epigenome and transcriptome. Sgf29, a subunit of the transcriptional co-activator complex SAGA, plays a critical role in a wide range of biological processes. However, whether and how Sgf29 mediates epigenetic modifications and pluripotency gene transcription is not fully understood. Herein, we found that Sgf29 knockout (KO) induced the differentiation of mouse ESCs (mESCs) by reducing H3K9ac and chromatin accessibility at the promoters and enhancers of key pluripotency genes. Interestingly, Sgf29 interacted with Oct4 and Nanog, but not Sox2, to co-regulate pluripotency genes. Sgf29 KO reduced the binding of Oct4 to the promoter and enhancer loci of Nanog and Klf4, leading to reduced expression of themselves and their downstream pluripotency-related genes. Furthermore, Sgf29 knockdown (KD) significantly reduced blastocyst rate and decreased H3K9ac at the blastocyst stage, leading to aberrant Oct4 and Nanog in the pre-implantation embryo. Together, these findings suggest that Sgf29 maintains chromatin accessibility and regulates the transcription of pluripotency-related genes by forming a functional complex with Oct4 and Nanog, playing a critical role in the regulation of pluripotent cell fate.
Indexed as
Identifiers
41843375What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.